Loading clinical trials...
Loading clinical trials...
This study will investigate the effects of rosiglitazone, a medicine commonly used to treat type 2 diabetes, on the utilization of glucose by the heart in patients with heart failure which is not due ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Stanford University
NCT05394506 · Laminopathies, Emery Dreifuss Muscular Dystrophy 2, and more
NCT07359690 · Heart Transplantation, Dilated Cardiomyopathy (DCM), and more
NCT07354646 · Myocardial Infarction (MI), Hypertrophic Cardiomyopathy (HCM), and more
NCT06922851 · Dilated Cardiomyopathy (DCM)
NCT04638621 · Dilated Cardiomyopathy
Stanford University Hospital
Stanford, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions